SEC-Show

BALCHEM CORP filed this 10-K on February 21, 2025

Back to Results Entire Filing Printer Friendly Outline

BALCHEM CORP - 10-K - 20250221 - SIGNATURES

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.


Date: February 21, 2025			BALCHEM CORPORATION
			By:/s/ Theodore L. Harris
			Theodore L. Harris, Chairman, President and
			and Chief Executive Officer

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed by the following persons on behalf of the registrant and in the capacities and on the dates indicated.


/s/ Theodore L. Harris
Theodore L. Harris, Chairman, President and
Chief Executive Officer
Date: February 21, 2025

/s/ C. Martin Bengtsson
C. Martin Bengtsson, Executive Vice President and
Chief Financial Officer
Date: February 21, 2025

/s/ William A. Backus
William A. Backus, Vice President and
Chief Accounting Officer
Date: February 21, 2025

/s/ David B. Fischer
David B. Fischer, Director
Date: February 21, 2025

/s/ Kathleen B. Fish
Kathleen B. Fish, Director
Date: February 21, 2025

/s/ Daniel E. Knutson
Daniel E. Knutson, Director
Date: February 21, 2025

/s/ Olivier Rigaud
Olivier Rigaud, Director
Date: February 21, 2025

/s/ Monica Vicente
Monica Vicente, Director
Date: February 21, 2025

/s/ Matthew D. Wineinger
Matthew D. Wineinger, Director
Date: February 21, 2025